LMB In The News


Smart neurons: single dendrites can perform computations

A study, published in the journal Nature and carried out by researchers based at the Wolfson Institute for Biomedical Research at UCL, LMB’s Tiago Branco and the University of North Carolina at Chapel Hill, succeeded in making incredibly challenging electrical and optical recordings directly from the tiny dendrites of neurons in the intact brain while the brain was processing visual information. More…

Published

Michael Neuberger 1953 – 2013

Professor Michael Neuberger, who has died aged 59, was a brilliant biochemist and immunologist whose work helped to launch a revolution in biomedical research.
More…

Published

MRC Annual Review 2012 – 13

Jason Chin and Phil Holliger’s research is featured in the Economy section of the new MRC Annual Review. More…

Published

Computer chemists win Nobel prize

The 2013 Nobel Prize in chemistry has gone to three scientists who “took the chemical experiment into cyberspace.” All three men spent varying periods at the LMB, in particular Michael Levitt who started his PhD at LMB at the end of the 1960s. More…

Published

Science in Action: Can We Cure Jet Lag?

The LMB’s Michael Hastings talks to the BBC’s Science in Action programme about the latest advance in body clock research. More…

Published

2013 Max Perutz Science Writing Award shortlist

Clara Sidor, CDF in the LMB’s Cell Biology Division, is shortlisted for the Max Perutz Science Writing Award. More…

Published

Biological clocks defy circadian rhythms

The LMB’s Mick Hastings is amongst a group of scientists that have shown marine animals have tidal and monthly timekeepers that work independently of daily cycle. More…

Published

Drug developed in Cambridge approved for treatment of multiple sclerosis

Approval concludes nearly 40-year epic journey from fundamental research, begun at LMB, to discovery of an effective treatment for active relapsing multiple sclerosis. More…

Published

Monoclonal antibodies; from their debut to blockbuster status

They’re found in home-testing kits for pregnancy, hospital tests for MRSA, and in six out of ten of the best-selling drugs today. But monoclonal antibodies have kept a surprisingly low profile since their debut in a Nature paper in 1975. This podcast follows them from that time through patent wars, promising drug trials and finally to blockbuster status today. Includes contributions from LMB’s Greg Winter.

Published

FORMA therapeutics and Cancer Research Technology to discover cancer drugs targeting deubiquitinating enzymes (DUBs)

LMB’s David Komander is part of collaborative consortium including FORMA Therapeutics and Cancer Research Technology, aiming to discover cancer drugs targeting deubiquitinating enzymes (DUBs). More…

Published